Company intelligence / Profile preview
Allen & Hanburys
London, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Allen & Hanburys was renowned for its pharmaceutical, infant food, and medical device products, most notably pioneering Ventolin (salbutamol) for asthma (the first selective β2-receptor agonist, launched in 1968). The company also produced malt extracts, cod liver oil preparations, medicated pastilles, and surgical instruments. Major clinical products such as Ventolin became foundational GSK respiratory assets after the company was acquired.
- Therapeutic areas
- DermatologyPulmonologyMetabolic DisordersOther
- Modalities
- Small moleculeBiologicDevice
- Industry
- Pharma
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Allen & Hanburys.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allen & Hanburys.